|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Investigating the cell of origin for bladder cancer
|
5R01CA193442-04
|
$474,774
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Tumor suppression, p53 and retrotransposons
|
1R01CA222579-01
|
$370,575
|
|
ABRAMS, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Mechanisms Underlying Functional Programs of Tumor-Associated Macrophages
|
5R01CA172105-04
|
$401,456
|
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
$154,969
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
$142,182
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Investigating mechanistic underpinnings and therapeutic potential of selective histone deacetylase and bromodomain inhibition for the treatment of non-small cell lung cancer
|
1K22CA222669-01
|
$182,485
|
|
ADEEGBE, OLAKUNLE
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
5R01CA211648-02
|
$432,788
|
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
Elucidation and therapeutic exploitation of PAK mediated radioresistance
|
1R37CA215081-01A1
|
$357,803
|
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-05
|
$922,200
|
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
|
5R00CA194309-04
|
$210,465
|
|
AIRD, KATHERINE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Role of Nix in pancreatic ductal adenocarcinoma
|
5F30CA200240-03
|
$49,524
|
|
ALAGESAN, BRINDA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-05
|
$1,223,634
|
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Treatment of glioma with nanocombretastatin with MRI monitoring
|
5R01CA206190-03
|
$344,269
|
|
ALI, MESER
|
Henry Ford Health System
|
|
Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies
|
5R01CA204639-03
|
$698,696
|
|
ALLIS, CHARLES
|
ROCKEFELLER UNIVERSITY
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-49
|
$2,645,581
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Regulation of mitosis by proteolysis in yeast
|
5R01CA206157-23
|
$289,175
|
|
AMON, ANGELIKA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Novel Dual Notch/PXR Targeting for Colon Cancer Therapy
|
5R01CA182872-05
|
$661,842
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Role of Tim-3 in determining T cell immunity
|
5R01CA187975-04
|
$377,666
|
|
ANDERSON, ANA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
|
5R01CA214018-02
|
$481,065
|
|
ANDERSON, CAROLYN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
A clones genomic stability as biomarker of its DNA-damage resilience
|
5K99CA215256-02
|
$166,644
|
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
Development of whole-brain in vivo 2HG imaging for precision medicine in mutant IDH glioma
|
5R01CA211080-02
|
$530,585
|
|
ANDRONESI, OVIDIU
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Clinical bacterial isolate engineered as an immunotherapy for prostate cancer
|
5F30CA203472-03
|
$49,524
|
|
ANKER, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-05
|
$605,293
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048339-25
|
$68,181
|
|
ARANETA, MARIA ROSARIO
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Leukemia Specific Splice Isoforms as Neo-Antigens for T-Cell Immunotherapy
|
5R01CA201225-03
|
$490,809
|
|
ARMISTEAD, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-24
|
$4,218,764
|
|
ARMSTRONG, GREGORY
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-09S1
|
$249,371
|
$2,494
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-05
|
$620,114
|
$155,029
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-06
|
$660,173
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Role of the mitochondrial citrate carrier SLC25A1(CIC)in cancer progression and therapy
|
5R01CA193698-04
|
$355,706
|
|
AVANTAGGIATI, MARIA
|
GEORGETOWN UNIVERSITY
|
|
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
|
5R01CA199137-04
|
$55,401
|
$13,850
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Collaborative Human Tissue Network (CHTN)
|
5UM1CA183713-05
|
$841,585
|
|
AYERS, LEONA
|
OHIO STATE UNIVERSITY
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
O-GlcNAcylation of Ewing sarcoma proteins in chromosomal maintenance
|
1R03CA223949-01
|
$89,000
|
|
AZUMA, MIZUKI
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Radiolabeled FASN Inhibitors for PET Imaging
|
5R21CA213157-02
|
$176,883
|
|
BABICH, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Improving Informal Caregivers and Cancer Survivors Psychological Distress, Symptom Management and Health Care Use
|
1R01CA224282-01A1
|
$650,204
|
$195,061
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design
|
1R01CA225615-01
|
$632,908
|
$632,908
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
DNA damage signaling to immune checkpoints
|
5R01CA204173-02
|
$376,715
|
|
BAKKENIST, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Interferon Activated Necroptosis as a New Therapeutic Avenue for Kidney Cancer
|
5R01CA168621-05
|
$379,725
|
|
BALACHANDRAN, SIDDHARTH
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-03
|
$848,325
|
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Systems genetics analysis of tumor evolution in the mouse
|
5R35CA210018-02
|
$951,000
|
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Depression Research for this search: $22,591,843
|